Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)

National Institutes of Health

MODERATE Tx General

Strategy Notes

—

Key Materials

—

Your Notes

Status & Deadline

Status: INELIGIBLE
Deadline: —
Cycle: —
Amount: —
Type: grant
URL: Apply

Update Status

Log Application

AI Pipeline

Research Programme Generate Draft

Status History

2026-07-22 OPEN → INELIGIBLE · The programme is a U.S. National Institutes of Health grant (U01) requiring the applicant to be a U.S.-based institution or eligible foreign institution with a U.S. partner; Eniola is an independent researcher in Nigeria without a U.S. institutional affiliation or co-investigator meeting NIH eligibility requirements.